Cargando…
The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology
Worldwide, Pseudomonas aeruginosa remains a leading nosocomial pathogen that is difficult to treat and constitutes a challenging menace to healthcare systems. P. aeruginosa shows increased and alarming resistance to carbapenems, long acknowledged as last-resort antibiotics for treatment of resistant...
Autores principales: | Hammoudi Halat, Dalal, Ayoub Moubareck, Carole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765337/ https://www.ncbi.nlm.nih.gov/pubmed/36568831 |
Ejemplares similares
-
The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens
por: Ayoub Moubareck, Carole, et al.
Publicado: (2022) -
The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria
por: Hammoudi Halat, Dalal, et al.
Publicado: (2020) -
Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen
por: Ayoub Moubareck, Carole, et al.
Publicado: (2020) -
Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa
por: Geitani, Regina, et al.
Publicado: (2019) -
Mobile Carbapenemase Genes in Pseudomonas aeruginosa
por: Yoon, Eun-Jeong, et al.
Publicado: (2021)